Figure 7

Tissue distribution and scheme summarising the protective effects of TJ-M2010-5 in spleen impairment. A Concentration of TJ-M2010-5 in different tissues collected at 30 min, 2, 6, 12 and 48 h after 30 mg/kg TJ-M2010-5 treatment. *P < 0.05, **P < 0.01, ***P < 0.001. B A schematic diagram of TJ-M2010-5 modulating the inflammatory response via PI3K/AKT3 pathway in spleen impairment.